Form 4 for BMEA Biomea Fusion, Inc.
Accepted 2023-06-02 00:00:00 ET · period of report 2023-05-31 · accession 0001859061-23-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-02 | 2023-05-31+ | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $34.11 | -125.0K | 3.55M | -3% | -$4.26M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-01 | S | D | 50,000 | $34.56 | 3,500,000 | D | — | — | (F2) A total of 50,000 shares were sold at an average price of 34.5633 in multiple transactions ranging from 34.50 to 35.02 Details of the specific transactions are available upon request. |
| 2 | Common | Common Stock | 2023-05-31 | S | D | 75,000 | $33.81 | 3,550,000 | D | — | — | (F1) A total of 75,000 shares were sold at an average price of 33.81 in multiple transactions ranging from 33.44 to 34.43. Details of the specific transactions are available upon request. |